Frazier Life Sciences Acquisition Corp. II Form SCHEDULE 13D — Oct 21, 2026
Frazier Life Sciences Acquisition Corp. II's sponsor group, led by Frazier Life Sciences Holdings II LLC and Dr. Albert Cha, filed a Schedule 13D disclosing beneficial ownership of 1,983,749 ordinary shares, or approximately 20.5% of the 9,675,000 shares outstanding following the SPAC's October 15, 2026 IPO of 7,500,000 Class A shares. The stake comprises 1,683,749 Class B sponsor shares (originally acquired for $25,000, with 277,311 shares forfeited) plus 300,000 Class A private placement shares purchased at $10.00 per share for $3.0 million.
Key figures
- Shares Outstanding
- 9675000
- Ipo Date
- 2026-10-15
- Ipo Shares
- 7500000
- Ownership Percent
- 20.5%
- Class BSponsor Shares
- 1683749
- Forfeited Class BShares
- 277311
- Private Placement Price
- $10.00 per share
- Private Placement Shares
- 300000
- Sponsor Initial Investment
- $25,000
- Beneficial Ownership Shares
- 1983749
- Forward Purchase Commitment Usd
- 25000000
- Forward Purchase Commitment Shares
- 2500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.